To refine your search through our archives use our Advanced Search
What a tough week for Lilly. On Aug. 12, a judge struck down the Indianapolis-based drugmaker’s U.S. patent on Strattera,
which might cost the company about $450 million in annual revenue. Then, five days later, Lilly halted clinical trials on
one
of its experimental Alzheimer’s medicines, because patients did worse on the drug than on a placebo.
Dr. Kevin Macadaeg, vice president of the Indiana Spine Group, talked about his physician
group's decision to build a 60,000-square-foot medical office and "bioskills" lab in Carmel next year, as well
as the group's commitment to grow independently in the face of pressures from hospital acquisitions and health reform.
Monroe Hospital in Bloomington is the latest target in the statewide buildup by hospital systems. St. Vincent Health, St.
Francis and at least one other system have all had talks in the past month with Monroe.
A 12-year-old boy was rushed to St. Vincent Hospital in critical condition after being pulled out of a pool Monday night at
the Pickwick Farms Apartments on the north side of Indianapolis. Police said the boy jumped in the water when no lifeguard
was on duty and he was unable to swim. Witnesses began CPR immediately after the boy was pulled from the pool until medics
arrived.
Batesville Community Schools delayed school by 90 minutes Tuesday morning because someone cut the tire valves on more than
half the buses in the system’s fleet. Sixteen of the school system’s 26 buses were damaged, according to school
superintendent Jim Roberts. Drivers from other school districts were able to drive the students to class this morning after
the delay.
Police took a man into custody Tuesday morning after an hours-long police standoff on the south side of Indianapolis. Shortly
after 9:30 a.m., special weapons and tactics team members entered a home on East Tabor Street and brought out a man in handcuffs.
Police have identified him as Dustin Denney. Witnesses say he fired about five shots into the air just after 7 a.m. Three
nearby IPS schools were on lockdown while the situation was unfolding. Fox59 will have more at 4 p.m.
The mandate from a U.S. bankruptcy judge will supply retroactive benefits to more than 6,000 Visteon Corp. retirees who lost
insurance coverage after
the
Michigan-based auto-parts maker filed for bankruptcy in 2009, including 2,100 workers in Indiana.
Arena Racing USA could be housed in Conseco Fieldhouse or Pepsi Coliseum starting in 2011. Tony Stewart and Joe Gibbs are among investors in new series.
Big Ten officials want nearly twice as much money as the Southeastern Conference is getting from CBS for its championship
football game.
JD Norman Industries advertisement tells employees that its proposal to buy the plant would guarantee
their GM transfer rights without having to close the facility.
The Laughner family has closed the Loon Lake Lodge in Castleton, ending a 122-year run of operating restaurants in Indianapolis.
The canal-side institutions are having trouble luring White River State Park visitors. Why not use retail to get them in the
doors?
The bus system’s announcement in May that its current service and fare structure will remain intact through 2011 helped to
extend the life of the route.
China and India are quickly moving toward reestablishing their historical roles as two of the world’s biggest economies.
Where will the U.S. fit in?
Precise Path Robotics completes round of funding on the heels of signing contract with two companies that control more than
100 U.S. golf courses.
Approval for the millions of Americans with chronic back or knee pain may add more than $500 million, or 16 percent, to Cymbalta’s
annual sales.
Pendleton-based company reported both higher profit and revenue, helped by a 20-percent increase in hybrid-motor sales.
The firm, now based in Chase Tower, wants to acquire and renovate the building at 241 N. Pennsylvania St.
Studies showed that the treatment did not slow the disease's progression. It's just the latest setback for the pharmaceutical
giant, which lost a patent lawsuit over a major drug last week and faces an unprecedented number of patent expirations through
2014.
